Sleep Interventions for Fibromyalgia
(SPIN-II Trial)
Trial Summary
What is the purpose of this trial?
Insomnia affects 67-88% of chronic pain patients. SPIN II is a randomized controlled clinical trial that will compare the effects of two cognitive behavioral sleep treatments in women with fibromyalgia and insomnia. This trial will yield important information about the roles of sleep, arousal, and brain structure and function in the development and maintenance of chronic pain in women with fibromyalgia.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any pain or sleep medications for at least one month before joining the trial.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia (CBT-I) and Sleep Hygiene Education (SHE) for fibromyalgia?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBT-I) significantly improves sleep, reduces fatigue, and alleviates anxiety and depression in fibromyalgia patients compared to Sleep Hygiene Education (SHE), which mainly improves subjective sleep quality. Additionally, combined CBT approaches focusing on both pain and insomnia have shown meaningful improvements in sleep quality and efficiency.12345
Is Cognitive Behavioral Therapy for Insomnia (CBT-I) safe for humans?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is generally considered safe for humans, as it is a non-drug treatment that focuses on changing sleep habits and behaviors. Studies have shown it can improve sleep and reduce symptoms in people with fibromyalgia without significant adverse effects.12345
How is Cognitive Behavioral Treatment-Insomnia (CBT-I) different from other treatments for fibromyalgia?
Cognitive Behavioral Treatment-Insomnia (CBT-I) is unique because it specifically targets insomnia, a common issue in fibromyalgia, and has been shown to improve sleep quality, fatigue, and mood more effectively than sleep hygiene education alone. Unlike other treatments that may focus solely on pain, CBT-I addresses the psychological aspects of insomnia, which can help alleviate other fibromyalgia symptoms.12356
Research Team
Christina McCrae, PhD
Principal Investigator
University of Missouri-Columbia
Eligibility Criteria
This trial is for women over 18 with fibromyalgia and insomnia who can read English. They shouldn't be taking pain or sleep medications for at least a month, have no major psychological issues besides depression or anxiety, no cognitive impairments, other sleep disorders, or be pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Cognitive Behavioral Treatment-Insomnia or Sleep Hygiene Education over 8 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6 and 12 months
Treatment Details
Interventions
- Cognitive Behavioral Treatment-Insomnia
- Sleep Hygiene Education
Cognitive Behavioral Treatment-Insomnia is already approved in United States, European Union for the following indications:
- Insomnia
- Chronic Pain Management
- Fibromyalgia
- Insomnia
- Chronic Pain Management
- Fibromyalgia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
University of Florida
Collaborator
National Institute of Nursing Research (NINR)
Collaborator